|22.25|| +0.13 / +0.59%|
Bruker Corp. designs, manufactures, services and markets proprietary life science and materials research systems and associated products that address the rapidly evolving needs of a diverse array of customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology and in-vitro diagnostics. Its technology platforms includes magnetic resonance technologies, mass spectrometry technologies, gas chromatography technologies, X-ray technologies, spark-optical emission spectroscopy, atomic force microscopy, stylus and optical metrology technology and infrared and Raman molecular spectroscopy technologies. It operates its business through two segments: Bruker Scientific Instruments and Bruker Energy and Supercon Technologies. The Bruker Scientific Instruments are organized into three operating segments: the Bruker BioSpin Group, the Bruker CALID Group and the Bruker Nano Group. Bruker was founded by Günther Laukien and Emil Bruker in 1960 and is headquartered in Billerica, MA.
|Frank H. Laukien||Chairman, President & Chief Executive Officer|
|Anthony L. Mattacchione||CFO, Senior VP-Corporate Finance & Accounting|
|Juergen Srega||Group President-Bruker CALID Segment|
|Stacey L. Desrochers||Treasurer|
|Thorsten Thiel||Head-Marketing & Public Relations|